Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sun Young Rha
A Phase II Study of Gemcitabine Monotherapy in Breast Cancer Patients Refractory to Anthracycline and Taxane
Cancer Research and Treatment
Cancer Research
Oncology
‹
1
2
Related publications
Evolving Approaches to Metastatic Breast Cancer Patients Pre-Treated With Anthracycline and Taxane
BioDrugs
Medicine
Biotechnology
Pharmacology
N0436 (Alliance): A Phase II Trial of Irinotecan With Cetuximab in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane-Containing Therapy
Clinical Breast Cancer
Cancer Research
Oncology
Gemcitabine and Oxaliplatin (GEMOX) in Gemcitabine Refractory Advanced Pancreatic Adenocarcinoma: A Phase II Study
British Journal of Cancer
Cancer Research
Oncology
A Multicenter Phase II Study of S-1 for Gemcitabine-Refractory Biliary Tract Cancer
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Single Agent Gemcitabine in Refractory or Relapsed Small-Cell Lung Cancer. Phase II Study
Research in Oncology
A Phase I/Ii Study of GLIF Combination Chemotherapy for Taxane/Platinum-Refractory/Resistant Endometrial Cancer (GOGO-EM2)
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Neoadjuvant Eribulin Mesylate Following Anthracycline and Taxane in Triple Negative Breast Cancer: Results From the HOPE Study
PLoS ONE
Multidisciplinary
Body Composition as a Predictor of Toxicity in Patients Receiving Anthracycline and Taxane–Based Chemotherapy for Early-Stage Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
Phase II Trial of Gemcitabine and Tanespimycin (17AAG) in Metastatic Pancreatic Cancer: A Mayo Clinic Phase II Consortium Study
Investigational New Drugs
Oncology
Pharmacology
